SlideShare una empresa de Scribd logo

Hungarian Investment and Trade Development Authority

•Descargar como PPT, PDF•
•
G
Global Sourcing Council

Hungary has a strong pharmaceutical industry with large international companies conducting R&D and manufacturing. It has a skilled workforce, lower costs than Western Europe, and university collaboration which supports the sector. Recent investments have expanded R&D, manufacturing, and clinical trials in Hungary. Clusters around universities in Budapest, Szeged, Debrecen and Pécs enhance academia-business cooperation in life sciences. Hungary also has regulatory systems harmonized with the EU and a competitive innovation ecosystem.

EmpresarialesEducación
1 de 14
 
Long t radition , n ew FDI into R&D ,[object Object],[object Object],[object Object]
WHY HUNGARY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Added value of the pharma sector
[object Object],[object Object],[object Object],[object Object],Life sciences A High Performing Sector
Latest investments in the life sciences sector ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Latest investments in the life sciences sector
Nanotechnology in Hungary ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Medical device manufacturing ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical trials ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Strong innovation capacity ,[object Object],Source: Global Comp e titiveness Report, World Economic Forum, 2006/ 2007 Ranking Country Switzerland 1 USA 2 Germany 5 France 19 Norway 21 Hungary 24 Czech Republic 30 Slovenia 33 Spain 49 China 56 Poland 64 Greece 76
Four life science clusters ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Genomnanotech Knowledge Centre Neurobiological Knowledge Centre Cell Communication Knowledge Centre Infobionics Knowledge Centre Medipolis Knowledge Centre Debrecen Szeged Budapest Pécs
Competitive wages compared to Western Europe Source: Mercer, 2007
Regulatory system ,[object Object],[object Object],[object Object],[object Object],[object Object]

Recomendados

HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
Business Turku
 
HealthBIO 2021_Opening words_Maarit Merla
HealthBIO 2021_Opening words_Maarit MerlaHealthBIO 2021_Opening words_Maarit Merla
HealthBIO 2021_Opening words_Maarit Merla
Business Turku
 
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
Business Turku
 
Innovation drives expansion, Titus Gylvin
Innovation drives expansion, Titus Gylvin Innovation drives expansion, Titus Gylvin
Innovation drives expansion, Titus Gylvin
Business Turku
 
Chapter 2: Trailblazing science
Chapter 2: Trailblazing scienceChapter 2: Trailblazing science
Chapter 2: Trailblazing science
Association of the British Pharmaceutical Industry (ABPI)
 
Life science instrumentations market
Life science instrumentations marketLife science instrumentations market
Life science instrumentations market
ameliasimon0
 
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum 2013 - Day 1 | Wolfgang Eberle EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum
 
Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...
Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...
Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...
KTN
 

Recomendados

HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
Business Turku
 
HealthBIO 2021_Opening words_Maarit Merla
HealthBIO 2021_Opening words_Maarit MerlaHealthBIO 2021_Opening words_Maarit Merla
HealthBIO 2021_Opening words_Maarit Merla
Business Turku
 
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
Business Turku
 
Innovation drives expansion, Titus Gylvin
Innovation drives expansion, Titus Gylvin Innovation drives expansion, Titus Gylvin
Innovation drives expansion, Titus Gylvin
Business Turku
 
Chapter 2: Trailblazing science
Chapter 2: Trailblazing scienceChapter 2: Trailblazing science
Chapter 2: Trailblazing science
Association of the British Pharmaceutical Industry (ABPI)
 
Life science instrumentations market
Life science instrumentations marketLife science instrumentations market
Life science instrumentations market
ameliasimon0
 
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum 2013 - Day 1 | Wolfgang Eberle EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum
 
Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...
Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...
Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...
KTN
 
Market elements of the biopharmaceutical market and single-use technologies
Market elements of the biopharmaceutical market and single-use technologiesMarket elements of the biopharmaceutical market and single-use technologies
Market elements of the biopharmaceutical market and single-use technologies
Benoit Massé
 
Case study examples from industry
Case study examples from industryCase study examples from industry
Case study examples from industry
Association of the British Pharmaceutical Industry (ABPI)
 
Chapter 5: The future
Chapter 5: The futureChapter 5: The future
Chapter 5: The future
Association of the British Pharmaceutical Industry (ABPI)
 
Technology scouting at Bayer Healthcare
Technology scouting at Bayer HealthcareTechnology scouting at Bayer Healthcare
Technology scouting at Bayer Healthcare
inosfera
 
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
Upgraded - Health Startup Association of Finland
 
How Patent and Regulatory Exclusivity can Protect Your Medical Device Business
How Patent and Regulatory Exclusivity can Protect Your Medical Device BusinessHow Patent and Regulatory Exclusivity can Protect Your Medical Device Business
How Patent and Regulatory Exclusivity can Protect Your Medical Device Business
Michael Weickert, Ph.D
 
Chapter 4: Letting innovation flourish
Chapter 4: Letting innovation flourishChapter 4: Letting innovation flourish
Chapter 4: Letting innovation flourish
Association of the British Pharmaceutical Industry (ABPI)
 
Chapter 3: Putting patients first
Chapter 3: Putting patients firstChapter 3: Putting patients first
Chapter 3: Putting patients first
Association of the British Pharmaceutical Industry (ABPI)
 
Merck & co., inc. barclays final 3-10-2015
Merck & co., inc. barclays final 3-10-2015Merck & co., inc. barclays final 3-10-2015
Merck & co., inc. barclays final 3-10-2015
Marcel Brussee
 
Merck group 7 strategic_mgmt
Merck group 7 strategic_mgmtMerck group 7 strategic_mgmt
Merck group 7 strategic_mgmt
kirtishankar075
 
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Will Roettger
 
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Vitor Pereira
 
Venipuncture needle and syringes market
Venipuncture needle and syringes marketVenipuncture needle and syringes market
Venipuncture needle and syringes market
Akshay Shinde
 
Innovative Infectious Disease Testing Technologies and Emerging Markets
Innovative Infectious Disease Testing Technologies and Emerging MarketsInnovative Infectious Disease Testing Technologies and Emerging Markets
Innovative Infectious Disease Testing Technologies and Emerging Markets
ReportsnReports
 
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
NarayanSharma67
 
Introduction to the pharmaceutical market and practice
Introduction to the pharmaceutical market and practiceIntroduction to the pharmaceutical market and practice
Introduction to the pharmaceutical market and practice
Wayne Wei
 
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
PhRMA
 
Antibody drug conjugate market opportunity analysis
Antibody drug conjugate market opportunity analysisAntibody drug conjugate market opportunity analysis
Antibody drug conjugate market opportunity analysis
Rajesh Sarma
 
Pharma figures 2017 ; Efpia
Pharma figures 2017 ; EfpiaPharma figures 2017 ; Efpia
Pharma figures 2017 ; Efpia
Guru Balaji .S
 
Blog april2016 companycreation
Blog april2016 companycreationBlog april2016 companycreation
Blog april2016 companycreation
Nutopya Life Science
 
ABA Life Sciences
ABA Life Sciences ABA Life Sciences
ABA Life Sciences
ABA - Invest in Austria
 
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystemImre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
CUBCCE Conference
 

Más contenido relacionado

La actualidad más candente

Technology scouting at Bayer Healthcare
Technology scouting at Bayer HealthcareTechnology scouting at Bayer Healthcare
Technology scouting at Bayer Healthcare
inosfera
 
How Patent and Regulatory Exclusivity can Protect Your Medical Device Business
How Patent and Regulatory Exclusivity can Protect Your Medical Device BusinessHow Patent and Regulatory Exclusivity can Protect Your Medical Device Business
How Patent and Regulatory Exclusivity can Protect Your Medical Device Business
Michael Weickert, Ph.D
 
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Will Roettger
 
Innovative Infectious Disease Testing Technologies and Emerging Markets
Innovative Infectious Disease Testing Technologies and Emerging MarketsInnovative Infectious Disease Testing Technologies and Emerging Markets
Innovative Infectious Disease Testing Technologies and Emerging Markets
ReportsnReports
 
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
PhRMA
 

La actualidad más candente (20)

Market elements of the biopharmaceutical market and single-use technologies
Market elements of the biopharmaceutical market and single-use technologiesMarket elements of the biopharmaceutical market and single-use technologies
Market elements of the biopharmaceutical market and single-use technologies
 
Case study examples from industry
Case study examples from industryCase study examples from industry
Case study examples from industry
 
Chapter 5: The future
Chapter 5: The futureChapter 5: The future
Chapter 5: The future
 
Technology scouting at Bayer Healthcare
Technology scouting at Bayer HealthcareTechnology scouting at Bayer Healthcare
Technology scouting at Bayer Healthcare
 
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
 
How Patent and Regulatory Exclusivity can Protect Your Medical Device Business
How Patent and Regulatory Exclusivity can Protect Your Medical Device BusinessHow Patent and Regulatory Exclusivity can Protect Your Medical Device Business
How Patent and Regulatory Exclusivity can Protect Your Medical Device Business
 
Chapter 4: Letting innovation flourish
Chapter 4: Letting innovation flourishChapter 4: Letting innovation flourish
Chapter 4: Letting innovation flourish
 
Chapter 3: Putting patients first
Chapter 3: Putting patients firstChapter 3: Putting patients first
Chapter 3: Putting patients first
 
Merck & co., inc. barclays final 3-10-2015
Merck & co., inc. barclays final 3-10-2015Merck & co., inc. barclays final 3-10-2015
Merck & co., inc. barclays final 3-10-2015
 
Merck group 7 strategic_mgmt
Merck group 7 strategic_mgmtMerck group 7 strategic_mgmt
Merck group 7 strategic_mgmt
 
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
 
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
 
Venipuncture needle and syringes market
Venipuncture needle and syringes marketVenipuncture needle and syringes market
Venipuncture needle and syringes market
 
Innovative Infectious Disease Testing Technologies and Emerging Markets
Innovative Infectious Disease Testing Technologies and Emerging MarketsInnovative Infectious Disease Testing Technologies and Emerging Markets
Innovative Infectious Disease Testing Technologies and Emerging Markets
 
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
 
Introduction to the pharmaceutical market and practice
Introduction to the pharmaceutical market and practiceIntroduction to the pharmaceutical market and practice
Introduction to the pharmaceutical market and practice
 
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
 
Antibody drug conjugate market opportunity analysis
Antibody drug conjugate market opportunity analysisAntibody drug conjugate market opportunity analysis
Antibody drug conjugate market opportunity analysis
 
Pharma figures 2017 ; Efpia
Pharma figures 2017 ; EfpiaPharma figures 2017 ; Efpia
Pharma figures 2017 ; Efpia
 
Blog april2016 companycreation
Blog april2016 companycreationBlog april2016 companycreation
Blog april2016 companycreation
 

Similar a Hungarian Investment and Trade Development Authority

Invest in Denmark Lifescience Cluster- Intro
Invest in Denmark Lifescience Cluster- IntroInvest in Denmark Lifescience Cluster- Intro
Invest in Denmark Lifescience Cluster- Intro
Pramila Das
 
Pharma in Switzerland
Pharma in SwitzerlandPharma in Switzerland
Pharma in Switzerland
Richard Gorst
 
2013 09 25_ildiko_innovation at teva
2013 09 25_ildiko_innovation at teva2013 09 25_ildiko_innovation at teva
2013 09 25_ildiko_innovation at teva
innovationday2013
 
Health Valley Event Presentatie Rob ten Hoedt
Health Valley Event Presentatie Rob ten HoedtHealth Valley Event Presentatie Rob ten Hoedt
Health Valley Event Presentatie Rob ten Hoedt
Health Valley
 
IMI Graham Hughes
IMI Graham HughesIMI Graham Hughes
IMI Graham Hughes
CK Group
 
H.A.E.Konarowski, Chemrar High-Teck Center
H.A.E.Konarowski, Chemrar High-Teck CenterH.A.E.Konarowski, Chemrar High-Teck Center
H.A.E.Konarowski, Chemrar High-Teck Center
Pharmcluster
 

Similar a Hungarian Investment and Trade Development Authority (20)

ABA Life Sciences
ABA Life Sciences ABA Life Sciences
ABA Life Sciences
 
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystemImre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
 
Μάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research ConferenceΜάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research Conference
 
Invest in Denmark Lifescience Cluster- Intro
Invest in Denmark Lifescience Cluster- IntroInvest in Denmark Lifescience Cluster- Intro
Invest in Denmark Lifescience Cluster- Intro
 
Procurement: The Cornerstone of Market Access in Europe
Procurement: The Cornerstone of Market Access in EuropeProcurement: The Cornerstone of Market Access in Europe
Procurement: The Cornerstone of Market Access in Europe
 
Pharma in Switzerland
Pharma in SwitzerlandPharma in Switzerland
Pharma in Switzerland
 
Finnish biotech year, Tero Piispanen
Finnish biotech year, Tero Piispanen Finnish biotech year, Tero Piispanen
Finnish biotech year, Tero Piispanen
 
2013 09 25_ildiko_innovation at teva
2013 09 25_ildiko_innovation at teva2013 09 25_ildiko_innovation at teva
2013 09 25_ildiko_innovation at teva
 
efpIA Figures key data_2013
efpIA Figures key data_2013efpIA Figures key data_2013
efpIA Figures key data_2013
 
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
 
Health Valley Event Presentatie Rob ten Hoedt
Health Valley Event Presentatie Rob ten HoedtHealth Valley Event Presentatie Rob ten Hoedt
Health Valley Event Presentatie Rob ten Hoedt
 
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
 
EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank Molina EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank Molina
 
IMI Graham Hughes
IMI Graham HughesIMI Graham Hughes
IMI Graham Hughes
 
Uott uw brochure 04 2018
Uott uw brochure 04 2018Uott uw brochure 04 2018
Uott uw brochure 04 2018
 
Europe In-Vitro Diagnostics (IVD) Market
Europe In-Vitro Diagnostics (IVD) MarketEurope In-Vitro Diagnostics (IVD) Market
Europe In-Vitro Diagnostics (IVD) Market
 
H.A.E.Konarowski, Chemrar High-Teck Center
H.A.E.Konarowski, Chemrar High-Teck CenterH.A.E.Konarowski, Chemrar High-Teck Center
H.A.E.Konarowski, Chemrar High-Teck Center
 
EPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de LooEPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de Loo
 
Transfer of novel academic research in vaccines into marketable products – a ...
Transfer of novel academic research in vaccines into marketable products – a ...Transfer of novel academic research in vaccines into marketable products – a ...
Transfer of novel academic research in vaccines into marketable products – a ...
 
4 nov 2010: Presentation Roland Lageveen on biotechnology in the NL.
4 nov 2010: Presentation Roland Lageveen on biotechnology in the NL. 4 nov 2010: Presentation Roland Lageveen on biotechnology in the NL.
4 nov 2010: Presentation Roland Lageveen on biotechnology in the NL.
 

Último

Byrd & Chen’s Canadian Tax Principles 2023-2024 Edition 1st edition Volumes I...
Byrd & Chen’s Canadian Tax Principles 2023-2024 Edition 1st edition Volumes I...Byrd & Chen’s Canadian Tax Principles 2023-2024 Edition 1st edition Volumes I...
Byrd & Chen’s Canadian Tax Principles 2023-2024 Edition 1st edition Volumes I...
ssuserf63bd7
 
Raising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE VenturesRaising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE Ventures
Alejandro Cremades
 
Stages of Startup Funding - An Explainer
Stages of Startup Funding - An ExplainerStages of Startup Funding - An Explainer
Stages of Startup Funding - An Explainer
Alejandro Cremades
 
Constitution of Company Article of Association
Constitution of Company Article of AssociationConstitution of Company Article of Association
Constitution of Company Article of Association
seri bangash
 
zidauu _business communication.pptx /pdf
zidauu _business communication.pptx /pdfzidauu _business communication.pptx /pdf
zidauu _business communication.pptx /pdf
zukhrafshabbir
 

Último (20)

Byrd & Chen’s Canadian Tax Principles 2023-2024 Edition 1st edition Volumes I...
Byrd & Chen’s Canadian Tax Principles 2023-2024 Edition 1st edition Volumes I...Byrd & Chen’s Canadian Tax Principles 2023-2024 Edition 1st edition Volumes I...
Byrd & Chen’s Canadian Tax Principles 2023-2024 Edition 1st edition Volumes I...
 
Raising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE VenturesRaising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE Ventures
 
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by AccionSeries A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
 
Stages of Startup Funding - An Explainer
Stages of Startup Funding - An ExplainerStages of Startup Funding - An Explainer
Stages of Startup Funding - An Explainer
 
Creative Ideas for Interactive Team Presentations
Creative Ideas for Interactive Team PresentationsCreative Ideas for Interactive Team Presentations
Creative Ideas for Interactive Team Presentations
 
Falcon Invoice Discounting Setup for Small Businesses
Falcon Invoice Discounting Setup for Small BusinessesFalcon Invoice Discounting Setup for Small Businesses
Falcon Invoice Discounting Setup for Small Businesses
 
Equinox Gold Corporate Deck May 24th 2024
Equinox Gold Corporate Deck May 24th 2024Equinox Gold Corporate Deck May 24th 2024
Equinox Gold Corporate Deck May 24th 2024
 
8 Questions B2B Commercial Teams Can Ask To Help Product Discovery
8 Questions B2B Commercial Teams Can Ask To Help Product Discovery8 Questions B2B Commercial Teams Can Ask To Help Product Discovery
8 Questions B2B Commercial Teams Can Ask To Help Product Discovery
 
Pitch Deck Teardown: Terra One's $7.5m Seed deck
Pitch Deck Teardown: Terra One's $7.5m Seed deckPitch Deck Teardown: Terra One's $7.5m Seed deck
Pitch Deck Teardown: Terra One's $7.5m Seed deck
 
Constitution of Company Article of Association
Constitution of Company Article of AssociationConstitution of Company Article of Association
Constitution of Company Article of Association
 
Unlock Your TikTok Potential: Free TikTok Likes with InstBlast
Unlock Your TikTok Potential: Free TikTok Likes with InstBlastUnlock Your TikTok Potential: Free TikTok Likes with InstBlast
Unlock Your TikTok Potential: Free TikTok Likes with InstBlast
 
How to Maintain Healthy Life style.pptx
How to Maintain Healthy Life style.pptxHow to Maintain Healthy Life style.pptx
How to Maintain Healthy Life style.pptx
 
Special Purpose Vehicle (Purpose, Formation & examples)
Special Purpose Vehicle (Purpose, Formation & examples)Special Purpose Vehicle (Purpose, Formation & examples)
Special Purpose Vehicle (Purpose, Formation & examples)
 
USA classified ads posting – best classified sites in usa.pdf
USA classified ads posting – best classified sites in usa.pdfUSA classified ads posting – best classified sites in usa.pdf
USA classified ads posting – best classified sites in usa.pdf
 
Copyright: What Creators and Users of Art Need to Know
Copyright: What Creators and Users of Art Need to KnowCopyright: What Creators and Users of Art Need to Know
Copyright: What Creators and Users of Art Need to Know
 
zidauu _business communication.pptx /pdf
zidauu _business communication.pptx /pdfzidauu _business communication.pptx /pdf
zidauu _business communication.pptx /pdf
 
Potato Flakes Manufacturing Plant Project Report.pdf
Potato Flakes Manufacturing Plant Project Report.pdfPotato Flakes Manufacturing Plant Project Report.pdf
Potato Flakes Manufacturing Plant Project Report.pdf
 
Evolution and Growth of Supply chain.pdf
Evolution and Growth of Supply chain.pdfEvolution and Growth of Supply chain.pdf
Evolution and Growth of Supply chain.pdf
 
Unveiling the Dynamic Gemini_ Personality Traits and Sign Dates.pptx
Unveiling the Dynamic Gemini_ Personality Traits and Sign Dates.pptxUnveiling the Dynamic Gemini_ Personality Traits and Sign Dates.pptx
Unveiling the Dynamic Gemini_ Personality Traits and Sign Dates.pptx
 
TriStar Gold Corporate Presentation May 2024
TriStar Gold Corporate Presentation May 2024TriStar Gold Corporate Presentation May 2024
TriStar Gold Corporate Presentation May 2024
 

Hungarian Investment and Trade Development Authority

  • 1.  
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13. Competitive wages compared to Western Europe Source: Mercer, 2007
  • 14.